Oral Abstract Presentation Session 3
Tracks
.
| Thursday, October 2, 2025 |
| 1:45 PM - 4:00 PM |
| Room 13 |
Overview
Chair:
Subarna Chakravorty
Presenters
Dr Subarna Chakravorty
Consultant Paediatric Haematologist
King's College Hospital Nhs Trust
Session Chair
Ms Inga Hegemann
Sr. Director Global Medical Affairs
Novo Nordisk Health Care Ag
Correlation of Non-Invasive Hemoglobin Measurement to Vaso-Occlusive Crises in Patients with Sickle Cell Disease
Dr Sheinei Alan
Director of Clinical Research
UVA School of Medicine Inova Campus, Department of Medicine/Inova Adult Sickle Cell Program
Real-World Data Demonstrating the Correlation Between Increased Fetal Hemoglobin and Reduced VOC Rates in SCD
Dr Aaron Cheng
Hematology Fellow
Hospital Of The University Of Pennsylvania
High Morbidity in Adults with Non-Transfusion-Dependent Thalassemia Referred to U.S. Specialty Centers
Dr Aditi Sinha
Junior Clinical Fellow
Kings College University Hospital Nhs Foundation Trust
A Single-Centre Experience of Bone Mineral Density Assessment in Adults with Sickle Cell Disease
Dr. Daniel Delfendahl
Resident
Uthsc
Reproductive Health in Women with Sickle Cell Disease – A Single Center Study
Dr Valeria Di Stefano
Dr
Fondazione Irccs Ca’ Granda Ospedale Maggiore Policlinico, Sc Medicina Ad Indirizzo Metabolico, Milan, Italy
Atrial Fibrillation Prevalence and Its Management in the Aging Transfusion-dependent Beta-thalassemia
Dr. Maria Dimopoulou
Head of the Department
Laikon General Hospital of Athens, Thalassemia Unit, Center of Expertise in Hemoglobinopathies
Prevalence, characteristics and outcome of monoclonal gammopathies in adult β-thalassemic patients: a single center experience
Miss Catarina Ginete
Phd Student
Health and Technology Research Center, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa
Pregnancy and SCD: Addressing the Gaps in Medical Surveillance in Low- and Middle-Income Countries
Mr John James
Chief Executive
Sickle Cell Society
Factors Influencing Participation in Sickle Cell Disease Clinical Trials: United Kingdom LISTEN Survey Findings
Dr Mbunya. S. Misiani, DBA
Advocacy Relations Consultant
Innovative Hematology Inc. (IHI)
Sickle Cell Disease ECHO: Kenya Leading with Care in Sub-Saharan Africa
